Plasma concentrations of tumour necrosis factor-alpha, tumour necrosis factor-related apoptosis-inducing ligand, and FasLigand/CD95L in patients with Chagas cardiomyopathy correlate with left ventricular dysfunction

European Journal of Heart Failure

Volumn 11, Issue 9, 2009, Pages 825-831

  Lula, Jamille Fernandes ^a   Rocha, Manoel Otavio Da Costa ^b   Nunes, Maria Do Carmo Pereira ^b   Ribeiro, Antônio Luiz Pinho ^b   Teixeira, Mauro Martins ^b   Bahia, Maria Terezinha ^a   Talvani, André ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

BNP; Chagas cardiomyopathy; FasLigand CD95L; Left ventricular dysfunction; TNF ; TRAIL

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; FAS LIGAND; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; BIOLOGICAL MARKER;

ADULT; APOPTOSIS; ARTICLE; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HUMAN; MALE; PRIORITY JOURNAL; ANALYSIS OF VARIANCE; BLOOD; CASE CONTROL STUDY; CHRONIC DISEASE; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; STATISTICAL MODEL; STATISTICS;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; FAS LIGAND PROTEIN; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 69249086480     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp105     Document Type: Article

References (30)

1. Bilate AM, Cunha-Neto E. Chagas disease cardiomyopathy: current concepts of an old Disease. Rev Inst Med Trop Sao Paulo 2008;2:67-74.
2. Rocha MO, Teixeira MM, Ribeiro AL. An update on the management of Chagas cardiomyopathy. Expert Rev Anti Infect Ther 2007;4:727-743.
3. Bishopric NH, Andreka P, Slepak T,Webster KA. Molecular mechanisms of apoptosis in the cardiac myocyte. Curr Opin Pharmacol 2001;1:141-150.
4. Nishida K, Yamaguchi O, Otsu K. Crosstalk between autophagy and apoptosis in heart Disease. Circ Res 2008;103:343-351.
5. Yndestad A, Damas JK, Geir Eiken H, Holm T, Haug T, Simonsen S, Froland SS, Gullestad L, Aukrust P. Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure. Cardiovasc Res 2002;54:178-182.
6. Gottlied RA, Gustafsson AB. Mechanisms of apoptosis in the heart. J Clin Immunol 2003;23:447-459.
7. Reeve JLV, Duffy AM, O'Brien T, Samali A. Don't lose heart-therapeutic value of apoptosis prevention in the treatment of cardiovascular disease. J Cell Mol Med 2005;9:609-622.
8. Zhang Z, Andrade ZA, Yu ZX, Andrade SG, Takeda K, Sadirgursky M, Ferrans VJ. Apoptosis in a canine model of acute Chagasic myocarditis. J Mol Cell Cardiol 1999; 31:581-596.
9. Tostes S Jr, Bertulucci Rocha-Rodrigues D, de Arau'jo Pereira G, Rodrigues V Jr. Myocardiocyte apoptosis in heart failure in chronic Chagas's disease. Int J Cardiol 2005;99:133-237.
10. Rodrigues V Jr, Agrelli GS, Leon SC, Silva Teixeira DN, Tostes S Jr, Rocha-Rodrigues DB. Fas/Fas-L expression, apoptosis and low proliferative response are associated with heart failure in patients with chronic Chagas' disease. Microbes Infect 2008;10:29-37.
11. Mead WF. Maximal exercise testing-Bruce protocol. J Fam Pract 1979;9:479-490.
12. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367.
13. Talvani A, Rocha MOC, Cogan J, Maewal P, deLemos J, Ribeiro ALP, Teixeira MM. Brain natriuretic peptide and left ventricular dysfunction in chagasic cardiomyopathy. Mem Inst Oswaldo Cruz 2004;99:645-649.
14. Punukollu G, Gowda RM, Khan IA, Navarro VS, Vasavada BC. Clinical aspects of the Chagas' heart disease. Int J Cardiol 2007;115:179-183.
15. Teixeira MM, Gazzinelli RT, Silva JS. Chemokines, inflammation and Trypanosoma cruzi Infection. Trends Parasitol 2002;18:262- 265.
16. Aoki Mdel P, Cano RC, Pellegrini AV, Tanos T, Guinazu NL, Coso OA, Gea S. Different signaling pathways are involved in cardiomyocyte survival induced by a Trypanosoma cruzi glycoprotein. Microbes Infect 2006;8:1723-1731.
17. Martins GA, Petkova SB, Machado FS, Kitsis RN, Weiss LM, Wittner M, Tanowitz HB, Silva JS. Fas-FasL interaction modulates nitric oxide production in Trypanosoma cruzi-infected mice. Immunology 2001;103:122- 129.
18. Fas SC, Fritzching B, Suri-Payer E, Krammer PH. Death receptor signaling and its function in the immune system. Curr Dir Autoimmun 2006;9:1-17.
19. Dunlay SM, Weston SA, Redfield MM, Killian JM, Roger VL. Tumor necrosis factor-alpha and mortality in heart failure: a community study. Circulation 2008; 118:625-631.
20. Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, Teixeira MM. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis 2004;38:943-950.
21. Chaudhari BR, Murphy RF, Agrawal DK. Following the TRAIL to apoptosis. Immunol Res 2006;35:249-262.
22. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995;6:673-682.
23. Michowitz Y, Goldstein E, Roth A, Afek A, Abashidze A, Ben Gal Y, Keren G, George J. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis. J Am Coll Cardiol 2005;45:1018-1024.
24. Miura Y, Tsujioka T, Nishimura Y, Sakaguchi H, Maeda M, Hayashi H, Dong M, Hyodoh F, Yata K, Wada H, Sugihara T, Otsuki T. TRAIL expression up-regulated by interferon-gamma via phosphorylation of STAT1 induces myeloma cell death. Anticancer Res 2006;26:4115-4124.
25. Talvani A, Ribeiro CS, Aliberti JCS, Michailowsky V, Santos PV, Murta SM, Romanha AJ, Almeida IC, Farber J, Lannes-Vieira J, Silva JS, Gazzinelli RT. Kinetic of cytokine gene expression in experimental chagasic cardiomyopathy- tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect 2000;2:851-866.
26. Gomes JA, Bahia-Oliveira LM, Rocha MO, Busek SC, Teixeira MM, Silva JS, Correa-Oliveira R. Type I chemokine receptors expression in Chagas's disease correlates with morbidity in cardiac patients. Infect Immun 2005;73: 7960-7966.
27. de Oliveira GM, Diniz RL, Batista W, Batista MM, Bani Correa C, de Arau'jo-Jorge TC, Henriques-Pons A. Fas ligand-dependet inflammatory regulation in acute myocardites induced by Trypanosoma cruzi infection. Am J Pathol 2007; 171:79-86.
28. Guilhermo LV, Silva EM, Ribeiro-Gomes FL, De Meis J, Pereira WF, Yagita H, DosReis GA, Lopes MF. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection. J Leukoc Biol 2007;81:941-951.
29. Filippatos G, Leche C, Sunga R, Tsoukas A, Anthopoulos P, Joshi I, Bifero A, Pick R, Uhal BD. Expression of FAS adjacent to fibrotic foci in the failing human heart is not associated with increased apoptosis. Am J Physiol 1999;277: H445-H451.
30. Heymans S, Hirsch E, Anker SD, Aukrust P, Balligand JL, Cohen-Tervaert JW, Drexler H, Fillippatos G, Felix SB, Gullestad L, Hilfiker-Kleiner D, Janssens S, Latini R, Neubauer G, Paulus WJ, Pieske B, Ponikowski P, Schroen B, Schultheiss HP, Tschope C, Van Bilsen M, Zannad F, McMurray J, Shah AM. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2009;11:119- 129.